Table 2. Selected perioperative outcomes by postoperative pain strategy in subgroups of patients with (A) preoperative FEV1 ≥80%, (B) 50–79%, and (C) <50% of predicted value.

FEV1 groupings	Outcomes of interest	LB	TEA	P value
A. FEV1 ≥80% of predicted		n=227	n=33
	Hospital LOS (days)	2 [1–16]	4 [1–14]	<0.001
	Patients with complication(s)	34 (15.0)	11 (33.3)	0.01
	Surgery type			<0.001
	Lobectomy	44 (19.4)	20 (60.6)
	Sublobar resection	183 (80.6)	13 (39.4)
B. FEV1 50–79% of predicted		n=88	n=23
	Hospital LOS (days)	2 [1–18]	4 [2–9]	<0.001
	Patients with complication(s)	15 (17.0)	5 (21.7)	0.56
	Surgery type			<0.001
	Lobectomy	18 (20.5)	17 (73.9)
	Sublobar resection	70 (79.5)	6 (26.1)
C. FEV1 <50% of predicted		n=11	n=9
	Hospital LOS (days)	7 [1–18]	6 [5–22]	0.94
	Patients with complication(s)	8 (72.7)	6 (66.7)	>0.99
	Surgery type			0.13
	Lobectomy	1 (9.1)	4 (44.4)
	Sublobar resection	10 (90.9)	5 (55.6)

Data are presented as median [range] or n (%). FEV1, forced expiratory volume in 1 second; LB, liposomal bupivacaine; TEA, thoracic epidural analgesia; LOS, length of stay.